About Us

Contact Us

Race
Home About Us Product News Order Career Contact

                                                                                                            

           APIs&Intermediates Chemicals of Shanghai APIs Chemical Co., Ltd 

          

Product Indentification
 

Name:   Afatinib
Synonyms:   BIBW2992;(S,E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
CAS Registry Number:   439081-18-2
Molecular Formula:   C24H25ClFN5O3
Molecular Weight:    485.937
Molecular Structure:  

 

           

                     In stock!

 

 

                   Appearance:  white crystalline powder

 

 

                   Purity:99%min

 

 

                   Storage: -20 C Keep in a dry place

 

 

                   For Research Used Only

 

 

                   Inquiry (H1NMR,HPLC,LC-MS)

 


 

 

Related Products:

 

            Lapatinib(231277-92-2)

 

             Afatinib(439081-18-2)   

 

          Neratinib(698387-09--6)   

 

          AEE788(497839-62-0)

 

         BMS-599626(8173837-23-1)

 

         Canertinib(267243-28-7)  

 

         Vandetanib(443913-73-3)

 

 

 

Related pages:


     Search Afatinib or BIBW2992  in google
     Search CAS 439081-18-2  in google
     Search C24H25ClFN5O3  in google

 

Related info:

 

       Afatinib (INN; planned trade name Tomtovok, previously Tovok) is a candidate drug against non-small cell lung carcinoma, developed by Boehringer Ingelheim. As of December 2008, it is undergoing a Phase III clinical trial for this indication, and Phase II trials for breast, prostate, and head and neck cancers, as well as glioma.

       In October 2010 a new Boehringer Ingelheim Phase III trial called "Lux-Lung 5" began with this drug.
 

 

 

 

Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click